Company guidance, FDA catalysts, dilution risk and cash runway, built from SEC, FDA and ClinicalTrials.gov filings and updated every day.
Follow RFL by emailGet an email when RFL pushes back a promised milestone, files for a stock offering or has an FDA decision. Free, no account needed.
We send one confirmation email first. Only emails about RFL, unsubscribe in one click. Privacy
📣 What RFL Says Is Next
second half of · ““We would also like to recognize the FDA for their long-term continued collaboration, and guidance in advancing this program.” “Following our pre-NDA meeting with the FDA, we believe we have a clear and expedited path forward reflective of the urgency and unmet need in NPC and expect to submit our NDA in the second half of calendar 2026.”
Company press release, Jun 11, 2026 · SEC filing
second half of 2026 · ““We would also like to recognize the FDA for their long-term continued collaboration, engagement and guidance in advancing this program.” “Having already completed our pre-NDA meeting with the FDA, we believe we have a clear, and expedited path forward reflective of the urgency and unmet need in NPC and expect to submit our NDA in the second half of 2026.”
Company press release, Jun 10, 2026 · SEC filing
second half of · “Topline data from the main study cohort is expected to be known and announced in the second half of calendar 2026.”
Company press release, Jun 10, 2026 · SEC filing
Quoted word for word from the company's press releases filed with the SEC. Timing is the company's own guidance, not a BioRadar estimate.
Get the full RFL picture
The 7-day free trial adds AI daily briefings, sentiment tracking, trial enrollment progress and email alerts for RFL and every other ticker you follow. Card required, cancel anytime.
Data: SEC EDGAR, FDA, ClinicalTrials.gov, Yahoo Finance • Informational purposes only, not investment advice. • All tracked stocks A–Z
This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.